您好,欢迎访问新疆农业科学院 机构知识库!

Ilex latifolia Improves the Anti-Tumor Effectiveness of Rapamycin Against Breast Cancer In Vitro and In Vivo

文献类型: 外文期刊

作者: Ren, Zhengnan 1 ; Wu, Yikuan 2 ; Guo, Xiaoying 3 ; Tian, Haizhi 4 ; Ou, Hongjing 1 ; Xiong, Zihan 1 ; Xiao, Yu 1 ; Xiao, Longquan 1 ; Li, Jing 1 ; Wu, Haibo 5 ; Wang, Xinhui 1 ;

作者机构: 1.Chengdu Univ, Coll Food & Biol Engn, Chengdu 610106, Peoples R China

2.Jiangnan Univ, Inst Sci & Technol, Wuxi 214122, Peoples R China

3.Sichuan Kelun Pharmaceut Co Ltd, Chengdu 610599, Peoples R China

4.Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Peoples R China

5.Xinjiang Acad Agr Sci, Turpan Inst Agr Sci, Turpan 838099, Peoples R China

关键词: Ilex latifolia; rapamycin; breast cancer; dietary intervention

期刊名称:FOODS ( 影响因子:5.1; 五年影响因子:5.6 )

ISSN:

年卷期: 2025 年 14 卷 9 期

页码:

收录情况: SCI

摘要: Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Although the mTOR inhibitor rapamycin exhibits notable anti-tumor activity, its clinical application is limited by metabolic side effects, particularly dyslipidemia. This study aimed to investigate the potential of Ilex latifolia (I. latifolia, large-leaf kudingcha), a traditional Chinese tea known for its lipid-lowering properties, to enhance the therapeutic efficacy of rapamycin in breast cancer. The combined effects of I. latifolia and low-dose rapamycin on tumor cell proliferation, cell cycle progression, apoptosis, and inflammation were assessed in four breast cancer cell lines and a murine breast cancer model. While low-dose I. latifolia alone exhibited limited anti-tumor activity, its combination with low-dose rapamycin synergistically inhibited tumor proliferation, induced cell cycle arrest, promoted apoptosis, and reduced inflammation in vitro. In vivo, dietary supplementation with I. latifolia mitigated rapamycin-induced lipid disturbances, reduced tumor growth, enhanced apoptosis, and alleviated inflammation in tumor tissues. These findings highlight I. latifolia as a promising dietary adjunct to rapamycin, providing a safer and more effective combinatorial strategy for breast cancer treatment.

  • 相关文献
作者其他论文 更多>>